Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1923 1
1950 4
1951 6
1952 5
1953 2
1954 2
1955 6
1957 2
1958 1
1959 2
1960 4
1961 8
1962 16
1963 16
1964 18
1965 12
1966 18
1967 32
1968 27
1969 38
1970 19
1971 25
1972 29
1973 34
1974 41
1975 39
1976 46
1977 35
1978 49
1979 36
1980 58
1981 58
1982 57
1983 83
1984 80
1985 84
1986 83
1987 90
1988 76
1989 106
1990 103
1991 135
1992 128
1993 177
1994 171
1995 175
1996 181
1997 198
1998 219
1999 220
2000 219
2001 219
2002 264
2003 254
2004 248
2005 235
2006 280
2007 305
2008 322
2009 291
2010 299
2011 362
2012 340
2013 419
2014 413
2015 430
2016 427
2017 445
2018 431
2019 455
2020 524
2021 606
2022 612
2023 491
2024 552
2025 462

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11,744 results

Results by year

Filters applied: . Clear all
Page 1
Generation of human adult hepatocyte organoids with metabolic functions.
Igarashi R, Oda M, Okada R, Yano T, Takahashi S, Pastuhov S, Matano M, Masuda N, Togasaki K, Ohta Y, Sato S, Hishiki T, Suematsu M, Itoh M, Fujii M, Sato T. Igarashi R, et al. Among authors: takahashi s. Nature. 2025 May;641(8065):1248-1257. doi: 10.1038/s41586-025-08861-y. Epub 2025 Apr 16. Nature. 2025. PMID: 40240606
Neoadjuvant Chemotherapy with Gemcitabine and S-1 versus Upfront Surgery for Resectable Pancreatic Cancer: Results of the Randomized Phase II/III Prep-02/JSAP05 Trial.
Unno M, Motoi F, Matsuyama Y, Satoi S, Toyama H, Matsumoto I, Aosasa S, Shirakawa H, Wada K, Fujii T, Yoshitomi H, Takahashi S, Sho M, Ueno H, Kosuge T. Unno M, et al. Among authors: takahashi s. Ann Surg. 2025 Apr 16. doi: 10.1097/SLA.0000000000006730. Online ahead of print. Ann Surg. 2025. PMID: 40235447
Microbial riboflavin inhibits ceramide synthase 3 to lower ceramide (d18:1/26:0) and delay colorectal cancer progression.
Qu R, Zhang Y, Kim B, Zeng G, Wang P, Shaoyong W, Huang Y, Guo W, Chen Y, Wang P, Yang Q, Lu S, Zhou X, Weng J, Xu J, Lin J, Wang K, Ma Y, Takahashi S, Luo Y, Yu X, Krausz KW, Pang Y, Hong T, Zhang Z, Fu W, Gonzalez FJ, Sun L. Qu R, et al. Among authors: takahashi s. Cell Metab. 2025 Sep 2;37(9):1852-1869.e8. doi: 10.1016/j.cmet.2025.06.002. Epub 2025 Jul 2. Cell Metab. 2025. PMID: 40609532
Atrial Translocation of Porphyromonas gingivalis Exacerbates Atrial Fibrosis and Atrial Fibrillation.
Miyauchi S, Kawada-Matsuo M, Furusho H, Nishi H, Nakajima A, Phat PT, Shiba F, Kitagawa M, Ouhara K, Oda N, Tokuyama T, Okubo Y, Okamura S, Takasaki T, Takahashi S, Hiyama T, Kawaguchi H, Komatsuzawa H, Miyauchi M, Nakano Y. Miyauchi S, et al. Among authors: takahashi s. Circulation. 2025 May 27;151(21):1527-1540. doi: 10.1161/CIRCULATIONAHA.124.071310. Epub 2025 Mar 18. Circulation. 2025. PMID: 40099365
Basal-shift transformation leads to EGFR therapy-resistance in human lung adenocarcinoma.
Shinozaki T, Togasaki K, Hamamoto J, Mitsuishi A, Fukushima T, Sugihara K, Ebisudani T, Okada M, Saito A, Shigematsu L, Takaoka H, Ito F, Ohgino K, Ishioka K, Watanabe K, Hishima T, Kurebayashi Y, Emoto K, Terai H, Ikemura S, Kawada I, Asakura K, Hishida T, Asamura H, Ohta Y, Takahashi S, Oda M, Saito M, Matano M, Soejima K, Fujii M, Fukunaga K, Yasuda H, Sato T. Shinozaki T, et al. Among authors: takahashi s. Nat Commun. 2025 May 11;16(1):4369. doi: 10.1038/s41467-025-59623-3. Nat Commun. 2025. PMID: 40350470 Free PMC article.
Cemiplimab in recurrent cervical cancer: Final analysis of overall survival in the phase III EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9 trial.
Oaknin A, Monk BJ, de Melo AC, Kim HS, Kim YM, Lisyanskaya AS, Samouëlian V, Lorusso D, Damian F, Chang CL, Gotovkin E, Takahashi S, Ramone D, Maćkowiak-Matejczyk B, Polastro L, Alia EMG, Colombo N, Makarova Y, Goh JC, Hasegawa K, Mora P, Pikiel J, Srivastav R, Rischin D, Rubio MJ, Perez J, Yoo SY, Gao B, Jamil S, Seebach F, Lowy I, Mathias M, Fury MG, Tewari KS. Oaknin A, et al. Among authors: takahashi s. Eur J Cancer. 2025 Feb 5;216:115146. doi: 10.1016/j.ejca.2024.115146. Epub 2025 Jan 10. Eur J Cancer. 2025. PMID: 39798514 Clinical Trial.
The Whole Picture of First-Line Osimertinib for EGFR Mutation-Positive Advanced NSCLC: Real-World Efficacy, Safety, Progression Pattern, and Posttreatment Therapy (Reiwa Study).
Watanabe K, Hosomi Y, Naoki K, Nakahara Y, Tsukita Y, Matsumoto H, Yoh K, Fujisaka Y, Takahashi S, Takata S, Usui K, Kishi K, Naka G, Tamano S, Uemura K, Kunitoh H. Watanabe K, et al. Among authors: takahashi s. JTO Clin Res Rep. 2024 Sep 7;5(11):100720. doi: 10.1016/j.jtocrr.2024.100720. eCollection 2024 Nov. JTO Clin Res Rep. 2024. PMID: 39416709 Free PMC article.
Tucatinib and trastuzumab in HER2-mutated metastatic breast cancer: a phase 2 basket trial.
Okines AFC, Curigliano G, Mizuno N, Oh DY, Rorive A, Soliman H, Takahashi S, Bekaii-Saab T, Burkard ME, Chung KY, Debruyne PR, Fox JR, Gambardella V, Gil-Martin M, Hamilton EP, Monk BJ, Nakamura Y, Nguyen D, O'Malley DM, Olawaiye AB, Pothuri B, Reck M, Sudo K, Sunakawa Y, Van Marcke C, Yu EY, Ramos J, Tan S, Bieda M, Stinchcombe TE, Pohlmann PR. Okines AFC, et al. Among authors: takahashi s. Nat Med. 2025 Mar;31(3):909-916. doi: 10.1038/s41591-024-03462-0. Epub 2025 Jan 17. Nat Med. 2025. PMID: 39825152 Free PMC article. Clinical Trial.
An organoid library unveils subtype-specific IGF-1 dependency via a YAP-AP1 axis in human small cell lung cancer.
Fukushima T, Togasaki K, Hamamoto J, Emoto K, Ebisudani T, Mitsuishi A, Sugihara K, Shinozaki T, Okada M, Saito A, Takaoka H, Ito F, Shigematsu L, Ohta Y, Takahashi S, Matano M, Kurebayashi Y, Ohgino K, Sato T, Kawada I, Asakura K, Hishida T, Asamura H, Ikemura S, Terai H, Soejima K, Oda M, Fujii M, Fukunaga K, Yasuda H, Sato T. Fukushima T, et al. Among authors: takahashi s. Nat Cancer. 2025 May;6(5):874-891. doi: 10.1038/s43018-025-00945-y. Epub 2025 Apr 30. Nat Cancer. 2025. PMID: 40307487
11,744 results
You have reached the last available page of results. Please see the User Guide for more information.